Angitia Incorporated Limited
Clinical trials sponsored by Angitia Incorporated Limited, explained in plain language.
-
New drug hopes to fortify fragile bones in brittle bone disease trial
Disease control Recruiting nowThis study tests an experimental drug called AGA2115 in 80 adults with osteogenesis imperfecta (brittle bone disease) types I, III, or IV. The goal is to see if it safely increases bone density compared to a placebo over 12 months. Participants must have a confirmed genetic diagn…
Phase: PHASE2 • Sponsor: Angitia Incorporated Limited • Aim: Disease control
Last updated May 26, 2026 09:40 UTC
-
Healthy volunteers needed to test new drug's journey through the body
Knowledge-focused Recruiting nowThis early-phase study aims to understand how a single dose of AGA2118 moves through and leaves the body in 30 healthy adults of Japanese, Chinese, and Caucasian descent. Participants must be 18-65, have adequate vitamin D levels, and agree to take calcium and vitamin D supplemen…
Phase: PHASE1 • Sponsor: Angitia Incorporated Limited • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC